Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Deals
Features
News
Region
Sectors
Size

US And Canada

AavantiBio activates with $107m
Sarepta Therapeutics provided $15m in a series A round for the company, which is advancing University of Florida research.
Astellas takes an Iota in acquisition deal
The UC Berkeley spinout has been snapped up by Astellas, two years after the latter took part in its series A round.
Disarm hands itself to Eli Lilly
Eli Lilly will acquire the WUSTL-linked neurological disease therapy developer in a $135m deal that could top $1.2bn with milestone payments.
Daily deal net: October 16, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Codiak Biosciences cracks IPO code
Codiak – based on research at Gothenburg and MD Anderson Cancer Center – has succeeded in going public after previously cancelling plans.
Agility Robotics escorts investors to $20m round
The OSU spinout plans to scale up the distribution of its robotics system, which has human-like legs to navigate complex environments.
TIAP absorbs state funding
The federal development board for Southern Ontario has injected $5m to accelerate the growth potential of TIAP's early-stage health sciences portfolio.
Kronos Bio crushes IPO to raise $250m
MIT's cancer drug developer Kronos Bio floated above its range in an upsized offering and saw its shares soar in price post-IPO.

Other News

Galecto elects to target $100m in IPO
Galecto has filed to go public nine years after being founded in Sweden to commercialise research from Lund and Edinburgh universities.
Daily deal net: October 12, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Daily deal net: October 9, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
UPMC crosses Abridge for $15m
Medical transcription technology provider Abridge has emerged from stealth with seed and series A funding.
Gamma Biosciences absorbs Nanopareil
Nanopareil employs nanofibre membranes to separate chemical compounds for the purposes of purifying biopharmaceutical candidates.
UNC-Chapel Hill celebrates commercialisation impact
Five-year commercialisation activity at the university is on the rise in terms of patents, inventions and licensing revenue.

Editor's Picks

Big deal: Ribon ties together $65m series B
Ribon Therapeutics has emerged out of stealth after three years of developing a lead asset targeting cancer based on research at MIT, UT Southwestern and Harvard Medical School.
Editorial: For the good of investors
As MedWhat scores an initial win in its courtroom battle with Stanford, Paige.ai finds itself in the middle of allegations that its licensing deal with Sloan Kettering was improper.
Big deal: Ambys arrives at $140m investment
Ambys Medicines has raised $60m in a series A round backed by Takeda and signed a strategic partnership agreement with the corporate worth $80m.
Big deal: QuantumScape fuels up on VW cash
VW will invest $100m in QuantumScape and form a joint venture with the Stanford spinout to develop batteries for long-range electric vehicles.
test reg

Login